Schrödinger to Participate in Upcoming Investor Conferences
November 06 2023 - 8:30AM
Business Wire
Schr�dinger (Nasdaq: SDGR), whose physics-based computational
platform is transforming the way therapeutics and materials are
discovered, today announced that management will participate in the
following conferences in November:
- Jefferies London Healthcare Conference: Fireside chat on
Wednesday, November 15, 2023, at 9:30 a.m. GMT (4:30 a.m. ET).
- Piper Sandler 35th Annual Healthcare Conference:
Fireside discussion on Wednesday, November 29, 2023, at 9:30 a.m.
ET.
The live discussions can be accessed under "News & Events"
in the investors section of Schr�dinger’s website,
https://ir.schrodinger.com/news-and-events/event-calendar and will
be archived for approximately seven days.
About Schr�dinger
Schr�dinger is transforming the way therapeutics and materials
are discovered. Schr�dinger has pioneered a physics-based
computational platform that enables discovery of high-quality,
novel molecules for drug development and materials applications
more rapidly and at lower cost compared to traditional methods. The
software platform is licensed by biopharmaceutical and industrial
companies, academic institutions, and government laboratories
around the world. Schr�dinger’s multidisciplinary drug discovery
team also leverages the software platform to advance a portfolio of
collaborative and proprietary programs to address unmet medical
needs.
Founded in 1990, Schr�dinger has approximately 800 employees and
is engaged with customers and collaborators in more than 70
countries. To learn more, visit www.schrodinger.com, follow us on
LinkedIn and Instagram, or visit our blog, Extrapolations.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231106880808/en/
Allie Nicodemo Schr�dinger, Inc. allie.nicodemo@schrodinger.com
617-356-2325
Schrodinger (NASDAQ:SDGR)
Historical Stock Chart
From Oct 2024 to Nov 2024
Schrodinger (NASDAQ:SDGR)
Historical Stock Chart
From Nov 2023 to Nov 2024